{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:09:25Z","timestamp":1789520965677,"version":"build-2803163510"},"reference-count":106,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbcan.2026.189701","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:47:21Z","timestamp":1788565641000},"page":"189701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunopeptidomics in gliomas: Decoding antigen presentation for precision immunotherapy"],"prefix":"10.1016","volume":"1881","author":[{"given":"Georgios","family":"Kallivokas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileia-Rafaella","family":"Karmaniola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis G.","family":"Vrettos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni-Kyriaki","family":"Vetsika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Piperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2026.189701_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101727","article-title":"The impact of immunopeptidomics: from basic research to clinical implementation","volume":"66","author":"Shapiro","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800145","article-title":"Immunopeptidomics special issue","volume":"18","author":"Ternette","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.bbcan.2026.189701_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102216","article-title":"New insights and approaches for analyses of immunopeptidomes","volume":"77","author":"Illing","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0020","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1042\/EBC20220246","article-title":"What do cancer-specific CD8+ T cells see? The contribution of immunopeptidomics","volume":"67","author":"Nicholas","year":"2023","journal-title":"Essays Biochem."},{"key":"10.1016\/j.bbcan.2026.189701_bb0025","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3390\/biology12121514","article-title":"Immunopeptidomics in the era of single-cell proteomics","volume":"12","author":"Mayer","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.bbcan.2026.189701_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007073","article-title":"Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery","volume":"11","author":"Zhang","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189701_bb0035","doi-asserted-by":"crossref","first-page":"801","DOI":"10.37349\/etat.2024.00249","article-title":"Immunopeptidomics in the cancer immunotherapy era","volume":"5","author":"Pongcharoen","year":"2024","journal-title":"Explor. Target. Antitumor Ther."},{"key":"10.1016\/j.bbcan.2026.189701_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1584688","article-title":"Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies","volume":"16","author":"Fu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1690464","article-title":"Recent advances in immunotherapy for gliomas: overcoming barriers and advancing precision strategies","volume":"16","author":"Jabri","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217640","article-title":"Pediatric gliomas immunity challenges and immunotherapy advances","volume":"618","author":"Vetsika","year":"2025","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2026.189701_bb0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41540-024-00482-x","article-title":"Immunopeptidomics for autoimmunity: unlocking the chamber of immune secrets","volume":"11","author":"Arshad","year":"2025","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.bbcan.2026.189701_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.642583","article-title":"Deciphering human leukocyte antigen susceptibility maps from Immunopeptidomics characterization in oncology and infections","volume":"11","author":"Juanes-Velasco","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"10.1016\/j.bbcan.2026.189701_bb0065","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer \u2014 mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2026.189701_bb0070","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0075","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/ni1516","article-title":"Recent advances in antigen processing and presentation","volume":"8","author":"Jensen","year":"2007","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.bbcan.2026.189701_bb0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nri3818","article-title":"The ins and outs of MHC class II-mediated antigen processing and presentation","volume":"15","author":"Roche","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","article-title":"Pathways of antigen processing","volume":"31","author":"Blum","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0090","article-title":"Overcoming immune evasion with innovative multi-target approaches for glioblastoma","volume":"16","author":"Su","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1133177","article-title":"Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA","volume":"14","author":"Celesti","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0100","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.RA120.002201","article-title":"CIITA-transduced glioblastoma Cells uncover a rich repertoire of clinically relevant tumor-associated HLA-II antigens","volume":"20","author":"Forlani","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbcan.2026.189701_bb0105","first-page":"iv19","article-title":"The glioma microenvironment and its impact on antitumor immunity","volume":"7","author":"Hansen","year":"2025","journal-title":"Neurooncol. Adv"},{"key":"10.1016\/j.bbcan.2026.189701_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100234","article-title":"Immunopeptidomics: Reading the immune signal that defines self from nonself","volume":"21","author":"Thibault","year":"2022","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbcan.2026.189701_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.101977","article-title":"Biology of HLA class I associated inflammatory diseases","volume":"38","author":"Bordbar","year":"2024","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0120","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1126\/science.aaf4384","article-title":"A large fraction of HLA class I ligands are proteasome-generated spliced peptides","volume":"354","author":"Liepe","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2026.189701_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01081","article-title":"HLA-class II artificial antigen presenting Cells in CD4+ T cell-based immunotherapy","volume":"10","author":"Couture","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102330","article-title":"Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells","volume":"83","author":"Macy","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0135","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41596-019-0133-y","article-title":"Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics","volume":"14","author":"Purcell","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bbcan.2026.189701_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.883989","article-title":"The importance of being presented: target validation by Immunopeptidomics for epitope-specific immunotherapies","volume":"13","author":"Becker","year":"2022","journal-title":"Front. Immunol."},{"issue":"7528","key":"10.1016\/j.bbcan.2026.189701_bb0145","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189701_bb0150","first-page":"1","article-title":"Recent advances in immunopeptidomic-based tumor neoantigen discovery","volume":"160","author":"Meng","year":"2023","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102342","article-title":"Game of Omes: ribosome profiling expands the MHC-I immunopeptidome","volume":"83","author":"Holly","year":"2023","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.bbcan.2026.189701_bb0160","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41587-021-01038-8","article-title":"Identification of tumor antigens with immunopeptidomics","volume":"40","author":"Chong","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0165","first-page":"1018","article-title":"Identification of the cryptic HLA-I immunopeptidome, Cancer","volume":"8","author":"Erhard","year":"2020","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0170","first-page":"62","article-title":"Mapping the MHC class I-spliced immunopeptidome of cancer cells, Cancer","volume":"7","author":"Liepe","year":"2019","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0175","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/s41467-020-14968-9","article-title":"Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes","volume":"11","author":"Chong","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189701_bb0180","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1158\/1078-0432.CCR-17-1839","article-title":"Identification of CRKII, CFL1, CNTN1, NME2, and TKT as novel and frequent T-cell targets in human IDH-mutant glioma","volume":"24","author":"Dettling","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891543","article-title":"Tumor-associated microenvironment of adult gliomas: a review","volume":"12","author":"Di Nunno","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70363","article-title":"Human leukocyte antigen (HLA) and tumor immunity: a critical link in Cancer immunotherapy","volume":"14","author":"Damian","year":"2026","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.bbcan.2026.189701_bb0195","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1349-7006.2006.00272.x","article-title":"Personalized peptide vaccines: a new therapeutic modality for cancer","volume":"97","author":"Itoh","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2026.189701_bb0200","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1158\/1078-0432.CCR-05-0559","article-title":"Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma","volume":"11","author":"Yajima","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0205","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1074\/mcp.RA119.001876","article-title":"Identification of tumor antigens in the HLA peptidome of patient-derived xenograft Tumors in mouse","volume":"19","author":"Rijensky","year":"2020","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbcan.2026.189701_bb0210","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2026.189701_bb0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumour-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0220","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/brain\/aws042","article-title":"Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy","volume":"135","author":"Dutoit","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.bbcan.2026.189701_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114312","article-title":"Considerations for personalized neoantigen vaccination in malignant glioma","volume":"186","author":"Dunn","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2026.189701_bb0230","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1561106","article-title":"Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma","volume":"8","author":"Johanns","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189701_bb0235","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189701_bb0240","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41586-018-0810-y","article-title":"Actively personalized vaccination trial for newly diagnosed glioblastoma","volume":"565","author":"Hilf","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189701_bb0245","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s43018-026-01199-y","article-title":"IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial","volume":"7","author":"Bunse","year":"2026","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bbcan.2026.189701_bb0250","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S1470-2045(17)30517-X","article-title":"Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial","volume":"18","author":"Weller","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0255","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1158\/1078-0432.CCR-11-3358","article-title":"Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein","volume":"19","author":"Crane","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0260","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/14760584.2020.1750376","article-title":"Personalized neoantigen vaccines: a glimmer of hope for glioblastoma","volume":"19","author":"Londhe","year":"2020","journal-title":"Expert Rev. Vaccines"},{"issue":"Supplement_1","key":"10.1016\/j.bbcan.2026.189701_bb0265","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/neuros\/nyz310_639","article-title":"Immunopeptidomics and peptide expression profiles to develop T-cell receptors against glioma-associated antigens","volume":"66","author":"Carrera","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bbcan.2026.189701_bb0270","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00401-018-1836-9","article-title":"The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy","volume":"135","author":"Neidert","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0275","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00401-017-1702-1","article-title":"Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens","volume":"134","author":"Rapp","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0280","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1158\/1078-0432.CCR-21-1881","article-title":"T-cell receptor therapy targeting mutant Capicua transcriptional repressor in experimental gliomas","volume":"28","author":"Kilian","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0285","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1084\/jem.20171046","article-title":"Novel and shared neoantigen derived from histone 3 variant H33K27M mutation for glioma T cell therapy","volume":"215","author":"Chheda","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbcan.2026.189701_bb0290","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.omto.2023.08.005","article-title":"Endogenous H33K27M derived peptide restricted to HLA-A\u221702:01 is insufficient for immune-targeting in diffuse midline glioma","volume":"30","author":"Wang","year":"2023","journal-title":"Mol. Ther. Oncolyt."},{"key":"10.1016\/j.bbcan.2026.189701_bb0295","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4963","article-title":"Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma","volume":"7","author":"Johnson","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2026.189701_bb0300","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1089\/hum.2012.041","article-title":"Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma","volume":"23","author":"Morgan","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbcan.2026.189701_bb0305","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejphar.2017.05.064","article-title":"The EGFR variant III mutant as a target for immunotherapy of glioblastoma multiforme","volume":"810","author":"Chistiakov","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0310","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221116120","article-title":"IRIS: big data-informed discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing","volume":"120","author":"Pan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbcan.2026.189701_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1124272","article-title":"Use of phage display biopanning as a tool to design CAR-T cells against glioma stem cells","volume":"13","author":"Potez","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0320","first-page":"1220","article-title":"TLR2 promotes glioma immune evasion by downregulating MHC class II molecules in microglia, Cancer","volume":"6","author":"Qian","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0325","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.devcel.2022.06.006","article-title":"Interferon-\u03b3 resistance and immune evasion in glioma develop via notch-regulated co-evolution of malignant and immune cells","volume":"57","author":"Parmigiani","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2026.189701_bb0330","article-title":"Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy","volume":"13","author":"D'Amico","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0335","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1044-579X(03)00025-7","article-title":"Hide-and-seek in the brain: a role for HLA-G mediating immune privilege for glioma cells","volume":"13","author":"Wiendl","year":"2003","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0340","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.168.9.4772","article-title":"A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape","volume":"168","author":"Wiendl","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0345","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1158\/2326-6066.CIR-18-0599","article-title":"Reduced neoantigen expression revealed by longitudinal multiomics as a possible immune evasion mechanism in glioma","volume":"7","author":"Nejo","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0350","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1158\/0008-5472.CAN-17-3714","article-title":"Computational characterization of suppressive immune microenvironments in glioblastoma","volume":"78","author":"Luoto","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0355","article-title":"Immune escape in glioblastoma: mechanisms of action and implications for immune checkpoint inhibitors and CAR T-cell therapy","volume":"12","author":"Yu","year":"2023","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.bbcan.2026.189701_bb0360","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1172\/JCI138760","article-title":"Glioma escape signature and clonal development under immune pressure","volume":"130","author":"Maire","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2026.189701_bb0365","doi-asserted-by":"crossref","first-page":"10162","DOI":"10.3390\/ijms241210162","article-title":"Exosomes as novel diagnostic biomarkers and therapeutic tools in gliomas","volume":"24","author":"Skouras","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189701_bb0370","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/cancers17162700","article-title":"The quest for non-invasive diagnosis: a review of liquid biopsy in glioblastoma","volume":"17","author":"Elias","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2026.189701_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1060000","article-title":"Effects of glioblastoma-derived extracellular vesicles on the functions of immune cells","volume":"11","author":"Musatova","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1069635","article-title":"Soluble HLA peptidome: a new resource for cancer biomarkers","volume":"12","author":"Tanuwidjaya","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0385","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1074\/mcp.RA119.001524","article-title":"Identification of tumor antigens among the HLA peptidomes of glioblastoma Tumors and plasma","volume":"18","author":"Shraibman","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"issue":"Supplement","key":"10.1016\/j.bbcan.2026.189701_bb0390","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1200\/JCO.2024.42.16_suppl.2073","article-title":"Small extracellular vesicles as a novel liquid biopsy approach for glioblastoma","volume":"42","author":"Deep","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0395","doi-asserted-by":"crossref","first-page":"11686","DOI":"10.3390\/ijms262311686","article-title":"Plasma extracellular vesicles as liquid biopsies for glioblastoma: biomarkers, subpopulation enrichment, and clinical translation","volume":"26","author":"Aibaidula","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189701_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2024.1611549","article-title":"Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment","volume":"30","author":"Dai","year":"2024","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0405","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s41416-023-02548-9","article-title":"Glioblastoma biomarkers in urinary extracellular vesicles reveal the potential for a \u2018liquid gold\u2019 biopsy","volume":"130","author":"Hallal","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2026.189701_bb0410","article-title":"An MHC-related gene's signature predicts prognosis and immune microenvironment infiltration in glioblastoma","volume":"26","author":"Yu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2026.189701_bb0415","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1158\/1055-9965.EPI-05-0136","article-title":"Positive and negative associations of human leukocyte antigen variants with the onset and prognosis of adult glioblastoma multiforme","volume":"14","author":"Tang","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.bbcan.2026.189701_bb0420","series-title":"T Cells and MHC Proteins","author":"Alberts","year":"2002"},{"key":"10.1016\/j.bbcan.2026.189701_bb0425","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","article-title":"GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas","volume":"603","author":"Majzner","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2026.189701_bb0430","article-title":"Investigative needle core biopsies support multimodal deep-data generation in glioblastoma","volume":"16","author":"Yu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189701_bb0435","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1295903","article-title":"Preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma","volume":"6","author":"Garg","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2026.189701_bb0440","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1136\/jitc-2024-009175","article-title":"Co-evolution of glioma and immune microenvironment","volume":"12","author":"Elguindy","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2026.189701_bb0445","doi-asserted-by":"crossref","DOI":"10.1177\/11769351221076062","article-title":"Liquid biopsy: a distinctive approach to the diagnosis and prognosis of cancer","volume":"21","author":"Hirahata","year":"2022","journal-title":"Cancer Inform."},{"key":"10.1016\/j.bbcan.2026.189701_bb0450","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00262-008-0493-6","article-title":"HLA typing demands for peptide-based anti-cancer vaccine","volume":"57","author":"Nagorsen","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2026.189701_bb0455","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1021\/pr4009207","article-title":"Large-scale mass spectrometric detection of variant peptides resulting from nonsynonymous nucleotide differences","volume":"13","author":"Sheynkman","year":"2014","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0460","article-title":"Harnessing noncanonical proteins for next-generation drug discovery and diagnosis","volume":"17","author":"Rajinikanth","year":"2025","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.bbcan.2026.189701_bb0465","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbcan.2026.189701_bb0470","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14789450.2018.1450631","article-title":"Affinity enrichment for MS: improving the yield of low abundance biomarkers","volume":"15","author":"Kim","year":"2018","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.bbcan.2026.189701_bb0475","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/acs.jproteome.0c00464","article-title":"Automated ligand purification platform accelerates immunopeptidome analysis by mass spectrometry","volume":"20","author":"Zhang","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbcan.2026.189701_bb0480","article-title":"Applications of multi-omics analysis in human diseases","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.bbcan.2026.189701_bb0485","doi-asserted-by":"crossref","first-page":"8926","DOI":"10.1038\/s41467-024-53296-0","article-title":"ImmuneApp for HLA-I epitope prediction and immunopeptidome analysis","volume":"15","author":"Xu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2026.189701_bb0490","doi-asserted-by":"crossref","DOI":"10.1002\/prca.70018","article-title":"Artificial intelligence and the evolving landscape of Immunopeptidomics","volume":"19","author":"Vo","year":"2025","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.bbcan.2026.189701_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115142","article-title":"Transketolase attenuates the chemotherapy sensitivity of glioma cells by modulating R-loop formation","volume":"44","author":"Fu","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2026.189701_bb0500","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/path.5835","article-title":"Integrative multi-omic analysis reveals neurodevelopmental gene dysregulation in CIC-knockout and IDH1-mutant cells","volume":"256","author":"Lee","year":"2022","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0505","doi-asserted-by":"crossref","first-page":"9091","DOI":"10.1126\/sciadv.adi9091","article-title":"H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patient","volume":"10","author":"Boschert","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bbcan.2026.189701_bb0510","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12672-024-01449-4","article-title":"Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma","volume":"15","author":"Zhuo","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0515","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1192448","article-title":"A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma","volume":"13","author":"Pandey","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2026.189701_bb0520","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.trecan.2024.10.008","article-title":"Generation of tumor neoantigens by RNA splicing perturbation","volume":"11","author":"Rosenberg-Mogilevsky","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbcan.2026.189701_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189126","article-title":"The neoantigens derived from transposable elements \u2013 a hidden treasure for cancer immunotherapy","volume":"1879","author":"Hu","year":"2024","journal-title":"Biochimica et biophysica acta. Reviews on cancer"},{"key":"10.1016\/j.bbcan.2026.189701_bb0530","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13035-2","article-title":"Transposable element expression in tumors is associated with immune infiltration and increased antigenicity","volume":"10","author":"Kong","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X26001733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:26:48Z","timestamp":1789518408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X26001733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0304419X26001733"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189701","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunopeptidomics in gliomas: Decoding antigen presentation for precision immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2026.189701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"189701"}}